The current P/E ratio for Mimedx Group stock as of Jun 5, 2025 is 23.48. This is calculated based on the TTM EPS of $0.27 and the stock price of $6.34 per share. The PE ratio has increased by 15% from its last 4 quarters average of 20.4.
The average historical PE ratio of Mimedx Group for the last ten years is 35.52. The current price-to-earnings ratio of 23.48 is 34% less than the historical average. Analyzing the last ten years, MDXG's PE ratio reached its highest point in the Dec 2016 quarter at 80.55, when the price was $8.86 and the EPS was $0.11. The lowest point was recorded in the Sep 2024 quarter, when it reached 9.38 with a price of $5.91 and an EPS of $0.63.
Maximum annual increase: 140.74% in 2016
Maximum annual decrease: -82.59% in 2015
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 33.17 | 51.25% | $9.62 | $0.29 |
2023 | 21.93 | N/A | $8.77 | $0.4 |
2022 | N/A | N/A | $2.78 | -$0.33 |
2021 | N/A | N/A | $6.04 | -$0.15 |
2020 | N/A | N/A | $9.08 | -$0.77 |
2019 | N/A | N/A | $7.58 | -$0.24 |
2018 | N/A | N/A | $1.79 | -$0.28 |
2017 | 20.67 | -74.34% | $12.61 | $0.61 |
2016 | 80.55 | 140.74% | $8.86 | $0.11 |
2015 | 33.46 | -82.59% | $9.37 | $0.28 |
2014 | 192.17 | N/A | $11.53 | $0.06 |
2013 | N/A | N/A | $8.74 | -$0.04 |
2012 | N/A | N/A | $3.84 | -$0.09 |
2011 | N/A | N/A | $1.13 | -$0.14 |
2010 | N/A | N/A | $1.35 | -$0.19 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 28.15 | -15.13% | $7.6 | $0.27 |
Dec 2024 | 33.17 | 253.62% | $9.62 | $0.29 |
Sep 2024 | 9.38 | -13.39% | $5.91 | $0.63 |
Jun 2024 | 10.83 | -26.87% | $6.93 | $0.64 |
Mar 2024 | 14.81 | -32.47% | $7.7 | $0.52 |
Dec 2023 | 21.93 | N/A | $8.77 | $0.4 |
Sep 2023 | N/A | N/A | $7.29 | -$0.02 |
Jun 2023 | N/A | N/A | $6.61 | -$0.17 |
Mar 2023 | N/A | N/A | $3.41 | -$0.28 |
Dec 2022 | N/A | N/A | $2.78 | -$0.33 |
Sep 2022 | N/A | N/A | $2.87 | -$0.31 |
Jun 2022 | N/A | N/A | $3.47 | -$0.26 |
Mar 2022 | N/A | N/A | $4.71 | -$0.18 |
Dec 2021 | N/A | N/A | $6.04 | -$0.15 |
Sep 2021 | N/A | N/A | $6.06 | -$0.33 |
The current PE ratio of MDXG is above its 3 and 5-year averages, but it is under its 10-year average.
When compared to its peer stocks MDT and STE, MDXG's PE ratio is lower.
Stock name | PE ratio | Market cap |
---|---|---|
MDXG Mimedx Group Inc | 23.81 | $949.72M |
MDT Medtronic plc | 26.31 | $111.71B |
TFX Teleflex Inc | 37.67 | $5.43B |
STE STERIS plc | 38.95 | $23.91B |
ATEC Alphatec Holdings Inc | N/A | $1.83B |
The price to earnings ratio for MDXG stock as of Jun 5, 2025, stands at 23.48.
The 3-year average PE ratio for MDXG stock is 19.71.
The 5-year average PE ratio for MDXG stock is 19.71.
The highest quarterly PE ratio in the last ten years has been 80.55 and it was in the Dec 2016 quarter.
The current PE ratio of MDXG is 34% lower than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 5, 2025), Mimedx Group's share price is $6.34. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.27. Therefore, Mimedx Group's price to earnings ratio for today is 23.48. PE RATIO(23.48) = STOCK PRICE($6.34) / TTM EPS($0.27)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.